Down-regulation of miR-497 is associated with poor prognosis in renal cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 1, 2015, Pages 758-764

  Zhao, Xiaolei ^a   Zhao, Zhenhua ^a   Xu, Wenchao ^a   Hou, Junqing ^a   Du, Xinyi ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

Biomarker; Clear cell renal cell carcinoma; miR 497; Prognosis

Indexed keywords

MICRORNA; MIRN497 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; BIOSYNTHESIS; DISEASE COURSE; DOWN REGULATION; FEMALE; GENETICS; HUMAN; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84923094129     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Lipworth L, Tarone RE and McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol 2006; 176: 2353-2358.
3. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF and Sinescu IC. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58: 398-406.
4. Rini BI, Campbell SC and Escudier B. Renal cell carcinoma. The Lancet 2009; 373: 1119-1132.
5. He L and Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
6. Croce CM and Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7.
7. Farazi TA, Spitzer JI, Morozov P and Tuschl T. miRNAs in human cancer. J Pathol 2011; 223: 102-115.
8. Zhang B, Pan X, Cobb GP and Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12.
9. Bartels CL and Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Clin Chem 2009; 55: 623-631.
10. Nana-Sinkam SP and Croce CM. MicroRNAs as therapeutic targets in cancer. Translational Research 2011; 157: 216-225.
11. Zhang BJ, Gong HY, Zheng F, Liu DJ and Liu HX. Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7: 6213.
12. Chu D, Zhao Z, Li Y, Li J, Zheng J, Wang W, Zhao Q and Ji G. Increased MicroRNA-630 Expression in Gastric Cancer Is Associated with Poor Overall Survival. PLoS One 2014; 9: e90526.
13. Cheng Z, Ma R, Tan W and Zhang L. MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2. Exp Mol Med 2014; 46: e112.
14. Li W, Liu M, Feng Y, Xu YF, Huang YF, Che JP, Wang GC, Yao XD and Zheng JH. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1). Br J Cancer 2014; 111: 1188-1200.
15. Edge SB and Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
16. Lam JS, Shvarts O, Leppert JT, Figlin RA and Belldegrun AS. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005; 173: 1853-1862.
17. Iorio MV and Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012; 4: 143-159.
18. Wang S, Li H, Wang J and Wang D. Expression of microRNA-497 and its prognostic significance in human breast cancer. Diagn Pathol 2013; 8: 172.
19. Luo M, Shen D, Zhou X, Chen X and Wang W. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery 2013; 153: 836-847.
20. Xu J, Wang T, Cao Z, Huang H, Li J, Liu W, Liu S, You L, Zhou L, Zhang T and Zhao Y. MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis. Oncotarget 2014; 5: 6983-6993.
21. Guo S, Jiang C, Wang G, Li Y, Wang C, Guo X, Yang R, Feng Y, Wang F and Tseng H. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 2012; 32: 1910-1920.